User profiles for Silvia Cerri
Silvia CerriGroup Leader,IRCCS Mondino Foundation Verified email at mondino.it Cited by 2581 |
[HTML][HTML] Parkinson's disease in women and men: what's the difference?
S Cerri, L Mus, F Blandini - Journal of Parkinson's disease, 2019 - content.iospress.com
Increasing evidence points to biological sex as an important factor in the development and
phenotypical expression of Parkinson’s disease (PD). Risk of developing PD is twice as high …
phenotypical expression of Parkinson’s disease (PD). Risk of developing PD is twice as high …
A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease
G Ambrosi, S Cerri, F Blandini - Journal of neural transmission, 2014 - Springer
Increased levels of extracellular glutamate and hyperactivation of glutamatergic receptors in
the basal ganglia trigger a critical cascade of events involving both intracellular pathways …
the basal ganglia trigger a critical cascade of events involving both intracellular pathways …
[PDF][PDF] Inefficient DNA repair is an aging-related modifier of Parkinson's disease
The underlying relation between Parkinson's disease (PD) etiopathology and its major risk
factor, aging, is largely unknown. In light of the causative link between genome stability and …
factor, aging, is largely unknown. In light of the causative link between genome stability and …
Role of autophagy in Parkinson's disease
S Cerri, F Blandini - Current medicinal chemistry, 2019 - ingentaconnect.com
Autophagy is an essential catabolic mechanism that delivers misfolded proteins and
damaged organelles to the lysosome for degradation. Autophagy pathways include …
damaged organelles to the lysosome for degradation. Autophagy pathways include …
[HTML][HTML] Glucocerebrosidase defects as a major risk factor for Parkinson's disease
Heterozygous mutations of the GBA1 gene, encoding for lysosomal enzyme glucocerebrosidase
(GCase), occur in a considerable percentage of all patients with sporadic Parkinson’s …
(GCase), occur in a considerable percentage of all patients with sporadic Parkinson’s …
[HTML][HTML] Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson's disease
The involvement of DNA damage and repair in aging processes is well established. Aging
is an unequivocal risk factor for chronic neurodegenerative diseases, underscoring the …
is an unequivocal risk factor for chronic neurodegenerative diseases, underscoring the …
Glucocerebrosidase mutations and synucleinopathies: toward a model of precision medicine
Glucocerebrosidase is a lysosomal enzyme. The characterization of a direct link between
mutations in the gene coding for glucocerebrosidase (GBA1) with the development of …
mutations in the gene coding for glucocerebrosidase (GBA1) with the development of …
[HTML][HTML] Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
…, E Tirotta, F Blandini, G Levandis, S Cerri… - Journal of …, 2016 - Springer
Background Parkinson’s disease (PD) is frequently associated with gastrointestinal (GI)
symptoms, including constipation and defecatory dysfunctions. The mechanisms underlying …
symptoms, including constipation and defecatory dysfunctions. The mechanisms underlying …
[HTML][HTML] The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients
S Cerri, C Ghezzi, M Sampieri, F Siani… - Frontiers in cellular …, 2018 - frontiersin.org
Intensive research efforts in the field of Parkinson’s disease (PD) are focusing on identifying
reliable biomarkers which possibly help physicians in predicting disease onset, diagnosis, …
reliable biomarkers which possibly help physicians in predicting disease onset, diagnosis, …
[HTML][HTML] Neuroprotective and symptomatic effects of cannabidiol in an animal model of Parkinson's disease
…, C Ghezzi, N Rossini, F Blandini, S Cerri - International Journal of …, 2021 - mdpi.com
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of
dopaminergic neurons in the Substantia Nigra pars compacta, leading to classical PD motor …
dopaminergic neurons in the Substantia Nigra pars compacta, leading to classical PD motor …